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Tubulin polymerization-promoting protein (TPPP), an
unfolded brain-specific protein interacts with the tubulin/mi-
crotubule system in vitro and in vivo, and is enriched in human
pathological brain inclusions. Here we show that TPPP induces
tubulin self-assembly into intact frequently bundled microtu-
bules, and that the phosphorylation of specific sites distinctly
affects the function of TPPP. In vitro phosphorylation of wild
type and the truncated form (3-43TPPP) of human recombi-
nant TPPP was performed by kinases involved in brain-specific
processes. A stoichiometry of 2.9 0.3, 2.2 0.3, and 0.9 0.1
mol P/mol protein with ERK2, cyclin-dependent kinase 5
(Cdk5), and cAMP-dependent protein kinase (PKA), respec-
tively, was revealed for the full-length protein, and 0.4–0.5 mol
P/mol protein was detected with all three kinases when the
N-terminal tail was deleted. The phosphorylation sites Thr14,
Ser18, Ser160 for Cdk5; Ser18, Ser160 for ERK2, and Ser32 for PKA
were identified by mass spectrometry. These sites were consist-
ent with the bioinformatic predictions. The three N-terminal
sites were also found to be phosphorylated in vivo in TPPP iso-
lated from bovine brain. Affinity binding experiments provided
evidence for the direct interaction between TPPP and ERK2.
ThephosphorylationofTPPPbyERK2orCdk5, butnot byPKA,
perturbed the structural alterations induced by the interaction
betweenTPPPand tubulinwithout affecting thebinding affinity
(Kd 2.5–2.7M) or the stoichiometry (1 mol TPPP/mol tubu-
lin) of the complex. The phosphorylation by ERK2 or Cdk5
resulted in the loss of microtubule-assembling activity of TPPP.
The combination of our in vitro and in vivo data suggests that
ERK2 can regulate TPPP activity via the phosphorylation of
Thr14 and/or Ser18 in its unfolded N-terminal tail.
Previously we isolated a new, flexible, intrinsically
unstructured protein from bovine brain, which was denoted
tubulin polymerization-promoting protein (TPPP)3/p25
accordingly to its in vitro function, tubulin polymerization-
promoting protein, and its molecular mass (1). In the HGNC
data base this protein is assigned as TPPP, the first member
of TPPP family. We have shown that TPPP can induce for-
mation of double-walled microtubules (MTs) and aberrant
tubulin aggregates (2) as well as that it stabilizesMT network
via its bundling activity in human cells (3). There are two
TPPP homologues, p18 (TPPP2) and p20 (TPPP3) with dis-
tinct structural and functional features concerning their
folding and tubulin binding properties (4). The physiological
functions of the TPPP protein family are unknown; however,
TPPP has been suggested to take part in the stabilization of
the MT network (3).
Both -synuclein and GAPDH directly bind to TPPP and
co-localize in the Lewy body (5–7). Our immunohistochemis-
try studies revealed enrichment of TPPP in -synuclein-posi-
tive inclusions characteristic for synucleinopathies but not for
tauopathies (5). TPPP is similar to -synuclein and tau (2, 8) as
far as all of them belong to the family of the unstructured
proteins.
Protein phosphorylation has a significant impact in the eti-
ology of neurodegenerative processes (9). For example, tau and
-synuclein, the major hallmarks of Parkinson and Alzheimer
diseases, respectively, are targets of different protein kinases.
One of the kinases phosphorylating tau with pathological rele-
vance in Alzheimer disease is cyclin-dependent kinase 5
(Cdk5), which is abundant in brain tissue, associates with tau
(10), and plays important role in the signaling of mitogen-acti-
vated protein kinases (MAP kinases) also called extracellular
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phorylate numerous KSPXK consensus motifs in diverse
cytoskeletal proteins and cross-talk in the regulation of neuro-
nal functions (11). The cAMP-dependent protein kinase (PKA)
interacts with the so-called A kinase-anchoring proteins via its
regulatory subunit, that targets the kinase activity to specific
subcellular locations (12) includingMTs through a direct bind-
ing to MAP2 (13, 14).
Currently there is limited information on the phosphoryla-
tion of TPPP, although it has been considered as a phosphopro-
tein (15). It was partially co-purified with tau protein kinase II
(also denoted Cdk5) from bovine brain extract; and two of the
Ser/Thr-Pro sites in synthetic peptides, segments of TPPP,
were phosphorylated by Cdk5 (15). Martin et al. (16) suggested
that rat brain TPPP could be phosphorylated near to stoichio-
metrically in vitro by Cdk5 and by PKA but practically not by
glycogen synthase kinase 3.
The aim of this work was to demonstrate that TPPP was able
to promote the formation of intact-like MTs exhibiting a func-
tion characteristic of MAPs, and to establish the effect of phos-
phorylation on the unfolded “structure” of TPPP, on its inter-
action with tubulin as well as on its MT promoting and
bundling activities. For these purposes we performed in vitro
phosphorylation studies with human recombinant TPPP and
with its truncated form, searched for the in vivo phosphoryla-
tion sites and interacting kinase partner(s), as well as studied
the functional consequences of the specific phosphorylation
events.
EXPERIMENTAL PROCEDURES
Materials—DTT, iodoacetamide, NH4HCO3, and 2,5-dihy-
droxybenzoic acid were obtained from Sigma, the sequencing
grade side-chain protected trypsin (modified by reductive
methylation) was ordered from Promega. C18 ZipTip was from
Millipore. MAP-free tubulin was purified from bovine brain as
described inRef. 17.Ni-NTAmagnetic agarose beadswere pur-
chased from Qiagen. TiO2 was from SunChrom GmbH.
An active complex of N-terminal His-tagged human Cdk5
and N-terminal glutathione S-transferase-tagged human p25
protein was obtained fromUpstate Biochemicals. The two pro-
teins were co-expressed in baculovirus-infected Sf21 insect
cells. The catalytic subunit of PKA isolated from bovine heart
was fromCalbiochem. The catalytic subunit was active without
the addition of cAMP. His-tagged activated human ERK2
expressed in Escherichia coliwas fromCalbiochem. [32P]ATP
was purchased from the Institute of Isotopes. Fine chemicals
and buffer components were from Sigma.
DNAManipulations—The coding region of humanTPPP (5)
was inserted into the XhoI and BamHI restriction sites of
pET15b vector (Novagen) producing pET15b-TPPP. A PCR
fragment for expression of 3-43TPPP, the deletion mutant
lacking residues 3-43, was generated using pET15b-TPPP
as template with the following primers: 5-GATACTCG-
AGATGGCTGCATCCCCTGAGCTCAGTGCCCTGGAG-
GAG-3 and 5-CCGTGGATCCCTACTTGCCCCCTTGC-
ACCTTCTGGTCGTAGG-3. The PCR fragment was inserted
into the XhoI and BamHI restriction sites of pET-15b producing
pET15b-3-43TPPP. Correct ligations were verified by DNA
sequencing.
Protein Purification—Recombinant human TPPP and p20
(TPPP3) were expressed in E. coli BL21 (DE3) cells and isolated
as described previously (4, 5). 3-43TPPP was expressed in
E. coli and was purified on HIS-SelectedTM Cartridge (Sigma
H8286) as the full-length TPPP.
Protein Determination—The protein concentration was
measured by the Bradford method (18) using the Bio-Rad pro-
tein assay kit.
Affinity Chromatography—Human recombinant TPPP was
immobilized to CNBr-activated Sepharose 4B (AmershamBio-
sciences) and used for finding interacting proteins from bovine
brain extract as described previously (6). The bound proteins
were eluted with 10 mM phosphate buffer, pH 7.0, containing
0.5 M NaCl, and the protein bands obtained by SDS-PAGE (19)
were analyzed by mass spectrometry.
Protein Phosphorylation—30 g of recombinant human
TPPP or its truncated form (3-43TPPP) or p20 protein
(TPPP3) were phosphorylated with PKA, ERK2, and Cdk5 in
vitro. A typical reactionmixture contained 50mMTris-HCl; pH
7.5 buffer supplemented with 1 mM benzamidine, 1 mM phen-
ylmethylsulfonyl fluoride, 1 mM EGTA, 10 mM NaF, 0.05 mM
sodium vanadate, 25 mM MgCl2, 0.2 mM ATP, and 0.4 g PKA
or 0.2 g of ERK2 in a final volume of 100 l. In one set of
experiments 30g of recombinant human TPPPwas phospho-
rylated with 0.1 g of ERK2 to reduce the degree of modifica-
tion. Phosphorylation with Cdk5 was conducted in the pres-
ence of 12 mM MOPS, pH 7.0 buffer, 0.2 mM EDTA, 1 mM
EGTA, 5mMNaF, 0.2mM sodium vanadate, 0.2mM dithiothre-
itol, 27 mM MgCl2, 0.2 mM ATP, and 0.05 g of kinase. About
107 cpmof [-32P]ATPwas added to themixture for radioactive
labeling. The reactions were initiated by the addition of the
kinase and were terminated with 50 mM EDTA. 5-l samples
were withdrawn at regular time intervals for quantitative anal-
ysis. Phosphate incorporation into the proteinswas determined
by themethod ofWitt andRoskoski (20) usingWhatmannP-81
filter paper. The radioactivity was counted by Tscherenkov
radiation. Aliquots of the samples were separated by SDS-
PAGE (19). Dried gels were analyzed by autoradiography
using RX Fuji medical x-ray films. According to the densito-
metric scanning of the films with a Bio-Rad Multi-Analyst
apparatus more than 90% of the incorporated radioactivity
was found in the monomeric and dimeric forms of the pro-
teins. A prestained protein ladder (Fermentas) was used for
the estimation of the molecular masses. Radioactive and cold
phosphorylation reactions were run parallel under identical
conditions. The degree of phosphorylation in the latter case
was checked by the method of back phosphorylation (21).
Only the non-radioactive samples were subjected to func-
tional studies and MS.
In-gel Digestion—Digestion with side chain-protected por-
cine trypsin proceeded at 37 °C for 4 h.
In-solution Digestion—Protein was dissolved in 6 M guani-
dine-HCl, disulfide bridges were reduced with dithiothreitol
and free sulfhydryls alkylatedwith iodoacetamide. Then sample
was diluted with 25 mM NH4HCO3 and digested with side
chain-protected porcine trypsin at 37 °C for 4 h.
Methyl Esterification—The protocol of Ficarro (22) was
applied.
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Phosphopeptide Enrichment by ImmobilizedMetal Ion Affin-
ity Chromatography—In NTA magnetic agarose beads Ni2
was displaced by Fe3 as described by Thompson et al. (23)
with final washing steps with a mixture of equal volumes of
water, methanol, and acetonitrile. Methyl-esterified sample
dissolved in water/methanol/acetonitrile was loaded onto the
beads and vortexed for 15 min, then beads were washed three
times with the loading solvent. Phosphopeptides were eluted
with 0.42% H3P04 in 50% acetonitrile. An aliquot of the eluate
was either directly analyzed by MALDI-TOF MS or diluted
with 0.1% formic acid and loaded on the trapping column for
LC-MS/MS.
Phosphopeptide Enrichment by TiO2—A modified proto-
col of Larsen et al. (24) was applied. The tryptic digest was
dried down, re-dissolved in 1% trifluoroacetic acid/50% ace-
tonitrile and mixed with TiO2 suspended in the same sol-
vent. After a few minutes vortexing the supernatant was dis-
carded, and TiO2 was washed three to five times with the
same solvent. Phosphopeptides were eluted with 1%
NH4OH.
MALDI-TOF MS and PSD Analysis—These analyses were
performed on a Bruker Reflex III MALDI-TOF mass spec-
trometer in 2,5-dihydroxy-benzoic acid matrix. Three point
external calibration was used with standard peptides. PSD
analysis was performed in 10–12 steps, lowering the reflec-
tron voltage by 25% at each step, and then stitching the data
together. While the MS conditions permitted monoisotopic
mass measurements, in PSD mode average masses were
determined.
LC-MS/MS—Samples were analyzed on an Agilent 1100
nanoLC system on-line coupled to an XCT Plus ion trap
mass spectrometer in information-dependent acquisition
mode. For phosphopeptide analysis, occasionally a preferred
mass list was included in data acquisition with m/z values
calculated from MALDI-TOF data or derived from previous
analyses. HPLC conditions were as follows: column: C18, 75
m 150mm; flow rate 300 nl/min; gradient: 5–45% B in 16
min, up to 90% B for 3 min, then equilibrated at 5% B for 15
min; solvent A was 0.1% formic acid in water, solvent B: 0.1%
formic acid in acetonitrile; trapping: 10 l/min flow rate, for
5 min in solvent A.
Data Base Search—MS and MS/MS data were searched
against the Swissprot 51.3 (250,296 sequences) and the NCBI
20070120 (4462937 sequences) non-redundant protein data-
bases using the Mascot search engine v2.1. Mass tolerance was
set according to the type of instrument and acquisition mode.
No species restriction was used. Data were also manually
inspected.
Bioinformatic Methods—For prediction of phosphorylation
and docking sites MotifScan (25) was used. Multiple sequence
alignment of vertebrate TPPPs was done by ClustalW (26).
CD Measurements—CD spectra were acquired with a
Jasco J-720 spectropolarimeter (Tokyo, Japan) in the 190–
260 nm wavelength range employing 0.1-cm thermostated
cuvettes at 25 °C, using 10 mM phosphate buffer (pH 7.0) as
described previously (4). During the titration of 1 M tubulin
the difference ellipticity at 207 nmwas determined as a func-
tion of the concentration of TPPP. Difference ellipticities
were calculated from the ellipticity measured at 207 nm in
the mixtures of two proteins and in the samples of the indi-
vidual proteins.
Turbidity Measurements—A total of 7 MMAP-free tubulin
was polymerized by 3 M TPPP before and after phosphoryla-
tion at 37 °C in 50 mM MES buffer, pH 6.6, containing 1 mM
dithiothreitol, 1mMEDTA, 1mMMgCl2, and 50mMKCl. In the
absence of TPPP no tubulin assembly occurs. Absorbance was
monitored at 350 nm by a Cary 50 spectrophotometer (Varian,
Australia).
Transmission ElectronMicroscopy (TEM)—The polymerized
tubulin samples were centrifuged at 30,000 g and 30 °C for 20
min and the pellet fraction was used for TEM. The pellets were
fixed for 1 h in a mixture of 2% glutaraldehyde, 0.2% freshly
prepared tannic acid, and 0.1 M sodium cacodylate (pH 7.4).
After washing in cacodylate, they were postfixed in 0.5% OsO4,
and embedded inDurcupan (Fluka, Switzerland). Thin sections
were contrasted with uranyl acetate and lead citrate and exam-
ined in a Jeol CX 100 electron microscope (1).
RESULTS
In Vitro Phosphorylation of TPPP—Recombinant human
TPPP was phosphorylated by protein kinases (ERK2, Cdk5,
and PKA) in the presence of [-32P]ATP under conditions to
reach maximal phosphorylation within 2 h (see “Experimen-
tal Procedures”). Fig. 1 shows typical SDS/PAGE protein
staining and autoradiographic images. Two characteristic
phosphoprotein bands of 26.5 and 63 kDa appeared in the
pictures corresponding to monomeric and dimeric species.
By the addition of an excess DTT to the samples all of the
dimers were converted to monomers (data not shown). The
radioactivity incorporated into TPPP was determined as
described under “Experimental Procedures”; the stoichiom-
etry of the phosphorylation was found to be 2.9  0.3, 2.2 
0.3, and 0.9  0.1 mol P/mol protein for ERK2, Cdk5, and
PKA kinases, respectively (Fig. 1).
The phosphorylated protein bands were excised from the
gels and digested with trypsin. After phosphopeptide enrich-
ment, samples were analyzed by MALDI-TOF MS, MALDI-
TOF PSD, and by LC-MS/MS on an ion trap mass spectrom-
eter. Phosphopeptides were first identified by the 80-Da
mass shift in comparison to the predicted molecular masses
of tryptic peptides. Their identity was further confirmed by
the -elimination of phosphoric acid (98 Da) from the pre-
cursor ion under collision-induced dissociation (CID) or
post source decay (PSD) conditions, a characteristic frag-
mentation step of Ser- and Thr-phosphorylated peptides
(27). The sites of phosphorylation were assigned considering
the 80 Da mass shift of the appropriate peptide fragments
(Table 1).
In agreementwith theminimal consensus of ERK2 andCdk5,
Ser, and Thr residues followed by Pro were targeted by these
kinases. From the total of 4 such sites in TPPP, Ser18, and Ser160
were phosphorylated by ERK2, while Thr14, Ser18, and Ser160
were modified by Cdk5. PKA phosphorylated Ser32 within the
single PKA consensus sequence KRLS in addition to Thr92 and
Ser159 residues, which are in a less favorable sequence environ-
ment and may represent minor or unspecific sites. Therefore,
MAP Kinase RegulatesMAP Functions of TPPP
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we conclude that under in vitro conditions Thr14, Ser18, Ser32,
and Ser160 of human TPPP are the main phosphorylation sites
of the MT-associated kinases.
Our structural prediction (8) suggested a quite extended
region in the N terminus of TPPP (1–52 amino acids) with
highly unfolded structure. As three of the main phosphoryla-
tion sites, Thr14, Ser18, and Ser32, are localized in this tail region
we expressed a truncated form of the human TPPP that lacks
the first 43 amino acid residues (3-43TPPP) and investigated
the consequences of this deletion. Fig. 1 demonstrates that the
truncation of the protein significantly reduced both the rate
and degree of its phosphorylation. A 0.4–0.5mol of P/mol pro-
tein stoichiometry was reached after 2 h of incubation with
ERK2, Cdk5, and PKA. As a negative control, the phosphoryla-
tion of recombinant humanp20 (TPPP3), a homologue ofTPPP
that lacks theN-terminal tail, and the phosphorylation site cor-
responding to Ser160 in TPPP was also tested under similar
conditions; and as expected virtually no 32P incorporation (0.02
mol of P/mol protein) was detected. These results suggest that
ERK2 and Cdk5 phosphorylate the residues Thr14 and Ser18 in
the N-terminal tail more vigorously than Ser160; and PKA effi-
ciently modifies Ser32 that is also localized in the N terminus.
Our data are consistent with the predictions by MotifScan (25)
for the probability of the phosphorylation sites by PKA, ERK2,
or Cdk5 (see Table 3).
In Vivo Phosphorylation of TPPP—To test if the in vitro phos-
phorylation sites are also relevant under in vivo conditions we
isolated TPPP from bovine brain as described previously (2),
and identified the phosphorylated sites of TPPP by MS. Phos-
phopeptides detected byMS without or after TiO2 enrichment
are summarized in Table 2. The PSD spectrum of the peptide at
MH 2954.5 produced fragments atm/z 1165.0 (y10), 1635.2
(y16), 1764.0 (y18), and 2077.2 (y22) revealing phosphorylation at
Ser30. A series of CID spectra unambiguously identified phos-
phorylation at Thr12, as listed in Table 2. Phosphorylation site
assignments were based on preferential peptide backbone
cleavages between 7LysPro8 and 12ThrPro13. Determination of
the phosphorylation sites in the doubly phosphorylated Ac-(2–
24) peptidewas performed from the quadruply charged precur-
sor at m/z 655.7 (Fig. 2). The fragment ion observed at m/z
665.9 can only be assigned as y122 with one phosphate in this
fragment, i.e. phosphorylation at Ser16. The fragment ion
observed atm/z 641.6 corresponds to the doubly phosphoryla-
ted y173 thus confirming an additional phosphate at position
Thr12.
The human and bovine TPPP proteins exhibit90% homol-
ogy (1) and carry the same phosphorylation sites, however,
because of the deletion of two amino acid residues at the N
terminus of the bovine protein the numbering of the phospho-
rylated residues is shifted (Fig. 3). Therefore, the in vivo phos-
phorylation sites identified in the bovine protein are in agree-
ment with those phosphorylated in vitro in human
recombinant TPPP (Table 3). Ser159 in the bovine protein cor-
responding to Ser160 in the human orthologwas not found to be
phosphorylated in vivo.
FIGURE 1. In vitro phosphorylation of human TPPP. Recombinant full-
length TPPP (lanes 1 and 3) and truncated 3-43TPPP (lanes 2 and 4) pro-
teins were phosphorylated in the presence of [32P]ATP with ERK2, Cdk5,
and PKA. Samples taken after 2 h of phosphorylation were separated in
10% SDS/PAGE, stained with Coomassie Brillant Blue (lanes 1 and 2), and
visualized by autoradiography (lanes 3 and 4) using 4 h (ERK2 and Cdk5) or
12 h (PKA) exposure of the photographic films. The positions of the stand-
ards (St) are marked, and their molecular masses are given in kDa. The
lower panel shows the time course and stoichiometry of phosphorylation
calculated from the radioactivity incorporated into the trichloroacetic
acid-insoluble proteins by ERK2 (f, ), Cdk5 (Œ, ‚), and PKA (, ƒ) as
measured with TPPP (full lines and filled symbols, 4 –6 independent exper-
iments) or with 3-43TPPP (broken lines and open symbols, two independ-
ent experiments), respectively.
TABLE 1
Identification of phosphorylation sites in human recombinant TPPP phosphorylated in vitro by Cdk5, ERK2, and PKA
Phosphorylated residues are indicated as pX, if MS/MS data enabled exact phosphorylation site determination. Residues are underlined where fragmentation produced y
and/or b ions that contributed to phosphorylation site determination. Methyl esterified Asp, Glu, and C-terminal residues are marked with apostrophe.
MH m/z Charge Sequence Position Enrichment Site Kinase
998.0 499.5 2 AISpSPTVSR 157–165	 TiO2 Ser-160 Cdk5, ERK2
1011.6 506.3 2 AIpSSPTVSR’ 157–165	 Fe-NTA Ser-159 PKA
1559.0 780.0 2 NVTVTD’VD’IVFSK’ 90–102	 Fe-NTA Thr-92 PKA
3081.7 1027.9 3 RLpSLE’S.E.’GAGE’GAAASPE’LSALE’E’AFRR’ 30–57	 Fe-NTA Ser-32 PKA
1874.5 625.5 3 AANRTPPKpSPGDPSKDR 10–26	 TiO2 Ser-18 Cdk5, ERK2
1462.3 488.1 3 TPPKpSPGDPSKDR 14–26	 TiO2 Ser-18 Cdk5, ERK2
1504.3 502.1 3 TPPKpSPGD’PSKD’R’ 14–26	 Fe-NTA Ser-18 Cdk5, ERK2
1218.6 609.8 2 TPPKpSPGD’PSK’ 14–24	 Fe-NTA Ser-18 Cdk5, ERK2
1915.9 1915.9 1 AANRpTPPKSPGD’PSKD’R’ 10–26	 Fe-NTA Thr-14 Cdk5
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Interaction of TPPP with ERK2—Next we investigated
whether the post-translational modification of TPPP was
assisted by a so-called dockingmechanism, i.e. by a direct inter-
action between TPPP and the kinase(s). For this purpose affin-
ity binding experiments were carried out by loading a crude
bovine brain extract on a TPPP-Sepharose column.
Fig. 4A shows the proteins that were bound to the affinity
column, and then eluted by 0.5 M NaCl. The two dominant
bands in the gel correspond to tubulin andGAPDH as reported
earlier (6). Between these two bands the marked band was
excised and in-gel digested with trypsin. The digest was ana-
lyzed by LC-MS/MS on an ion trap mass spectrometer. In the
digest ERK2 (NCBI acc. NP_786987) was identified from the
MS/MS spectra of peptides m/z 643.16 (2), m/z 651.0 (2)
(Fig. 4B), and m/z 974.6 (1) revealing the sequences
Ac-AAAAAAGAGPEMVR (2–15), Ac-AAAAAAGAGPE-
M(ox)VR (2–15), and GQVFDVGPR (16–24), respectively. In
addition, MotifScan (25) analysis predicted ERK docking sites
in TPPP, one of them containing the characteristic LXL
sequence motif (28) in the N-terminal region. The finding that
ERK2 can directly bind to TPPP underlines the significance of
this kinase in the post-translational
modification of Ser/Thr-Pro resi-
dues in TPPP.
Effect of Phosphorylation on the
Interaction of TPPP with Tubulin—
As shown in Fig. 5A, the human
recombinant TPPP displays a CD
spectrum with a minimum at 205
nm that is characteristic for the
unstructured proteins. We found
that phosphorylation by ERK2,
Cdk5, or PKA did not perturb the
CD spectrum (data not shown) indi-
cating that the phosphorylation did
not elicit detectable changes in the
secondary structure of the protein.
We confirmed our previous data (2)
that the addition of tubulin to TPPP
altered the CD spectrum signifi-
cantly, and demonstrated that the
phosphorylation of TPPP by ERK2
with a stoichiometry of 2.9 P/mol
protein modified the spectrum of
the TPPP-tubulin complex (Fig.
5A). The phosphorylation decreased the binding-induced
structural changes (the difference of the ellipticity obtained
with the mixture compared with the sum of the individual pro-
teins). The phosphorylation of TPPP by Cdk5 (2.2 P/mol pro-
tein) had a similar effect, while the phosphorylation with PKA
(0.9 P/mol protein) had no effect (data not shown). Thus our
data suggest that ERK2 or Cdk5 can perturb the interaction of
TPPP with tubulin, in contrast to PKA that is ineffective in this
respect.
For the evaluation of the role of phosphorylation on the
characteristics of the TPPP-tubulin interaction, the elliptic-
ity differences were determined from the CD spectra meas-
ured at varying concentrations of TPPP before and after its
phosphorylation. Fig. 5B shows that although the phospho-
rylation significantly reduced the difference ellipticity at the
saturation levels (characteristic for the secondary structure
elements), the dissociation constants (Kd 2.5–2.7 M) and
the stoichiometry (
1 mol TPPP/mol tubulin) estimated
from the Wu-Hammes plots were not changed significantly
(Fig. 5C).
FIGURE 2. Identification of phospho-Thr12 and phospho-Ser16 of TPPP isolated frombovine brain. CID of
the precursor atm/z 655.7 (4) confirmed the identity of the doubly phosphorylated Ac-ADSRPKPANKpTPP-
KpSPGEPAKDK (2–24) peptide. Fragments assigned as y12
2 and y17
3 unambiguously identified Thr12 and
Ser16 being phosphorylated.
TABLE 2
In vivo phosphorylated peptides identified by MALDI-TOFMS and/or LC-MS/MS in tryptic digests of TPPP isolated from bovine brain
Phosphorylated residues are indicated as pX, if MS/MS data enabled exact phosphorylation site determination. Residues are underlined where fragmentation produced y
and/or b ions that contributed to phosphorylation site determination. All of the peptides were enriched by TiO2 except for the last modified peptide that was detected by
MALDI-TOF MS without enrichment.
MH Precursorm/z Charge Sequence Position No. of phosphate Site(s)
2295.2 575.0 4 Ac-ADSRPKPANKpTPPKSPGEPAK Ac-2–22	 1 Thr-12
2410.5 603.6 4 Ac-ADSRPKPANKpTPPKSPGEPAKD Ac-2–23	 1 Thr-12
2410.5 483.1 5 Ac-ADSRPKPANKpTPPKSPGEPAKD Ac-2–23	 1 Thr-12
2538.5 508.9 5 Ac-ADSRPKPANKpTPPKSPGEPAKDK Ac-2–24	 1 Thr-12
2618.5 655.7 4 Ac-ADSRPKPANKpTPPKpSPGEPAKDK Ac-2–24	 2 Thr-12, Ser-16
2680.6 537.1 5 Ac-ADSRPKPANKpTPPKSPGEPAKDKAA Ac-2–26	 1 Thr-12
2680.6 671.0 4 Ac-ADSRPKPANKpTPPKSPGEPAKDKAA Ac-2–26	 1 Thr-12
2760.6 691.3 4 Ac-ADSRPKPANKTPPKSPGEPAKDKAA Ac-2–26	 2
2808.7 562.7 5 Ac-ADSRPKPANKTPPKSPGEPAKDKAAK Ac-2–27	 1
2954.9 2954.9 1 RLpSLEAEGAGEGAAAAGAELSALEEAFRK 28–56	 1 Ser-30
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Assembly of MTs Induced by TPPP and the Effect of Phospho-
rylation on This Process—Previously we reported that TPPP
promotes tubulin polymerization into aberrant, sometimes
double-walled, tubules as well as into large aggregates (1). Now
we found the conditions at which TPPP was able to induce the
formation of intact-like MTs. The addition of 3 M TPPP to 7
M MAP-free tubulin in the polymerization buffer at 37 °C
induced tubulin polymerization as detected by turbidimetry
(Fig. 5D). TEM analysis of the pellet fraction revealed the
appearance of large amounts of MTs,
25–26 nm in diameter,
the majority of which formed bundles consisting of dozens of
MTs (Fig. 6A). The MTs were frequently decorated by rows of
tiny projections and dense particles with a periodicity of about
16 nm. The particles appear to connectMTs in the bundle (Fig.
6B). These pictures provide the first experimental evidence that
TPPP induces intact-likeMTs.Another characteristicmorpho-
logical feature of these samples, beside the single and bundled
MTs, is the presence of thread-like oligomers. The threads are

15 nm in diameter and are concentrated in densely packed
knobs between the bundles of MTs (Fig. 6A).
The effect of phosphorylation on the ability of TPPP to pro-
mote tubulin polymerization was also analyzed by time-
dependent turbidity measurements. In contrast to the control
(no phosphorylation) the ERK2-mediated modification of
TPPP (2.9 mol P/mol protein) completely blocked tubulin
polymerization (Fig. 5D). The inhibition was so extensive that
prevented a TEM analysis, as it was impossible to collect poly-
merized species by centrifugation. The Cdk5-mediated phos-
phorylation diminished the assembly activity of TPPP as well,
however, PKA was ineffective (data not shown).
We tested whether a partially phosphorylated TPPP main-
tained any MT assembling activity. In a specific set of experi-
FIGURE 3. A, multiple sequence alignment of the N-terminal tail of vertebrate TPPPs by ClustalW (26) Hs, Homo sapiens; Bt, Bos taurus;Mum,Mus musculus; Pt,
Pan troglydes; Mam, Macaca mulatta; Rn, Rattus norvegicus; Cf, Canis familiaris; Md, Monodelphis domestica; Gg, Gallus gallus; Fr, Fugu rubripes; Tn, Tetraodon
nigroviridis;Dr,Danio rerio.Residues identical and similar in all species are indicatedbyblackandgraybackgrounds, respectively. Putativephosphorylation sites
are indicated with bold characters. Amino acid residues found to be phosphorylated in vivo or in vitro are labeled with x (see Table 3). The numbering refers to
the human TPPP. B, alignment of TPPPwith one of theMT binding sites of tau protein.Hs,H. sapiens; Bt, B. taurus;Mum,M. musculus. This part of the sequence
of tau is identical in the three species. Residues identical with and similar to the tau amino acid residues are indicated by black and gray backgrounds,
respectively.
TABLE 3
Summary of the phosphorylation sites in TPPP
Kinases
Phosphorylated sites
Thr Ser Ser Ser
ba hb mc b h m b h m b h m
12 14 15 16 18 19 30 32 31 159 160 159
Probabilityd
CDK5 Medium Medium Low
ERK2 Low Medium Low
PKA High
In vitro
CDK5  e e
ERK2  
PKA 
In vivo ff ff ff
a b, bovine.
b h, human.
cm, mouse.
d Probability of phosphorylation predicted byMotifScan.High stringency indicates that themotif identified in the query sequence iswithin the top 0.2%of allmatching sequences
contained in vertebrate Swiss-Prot protein database. Medium and low stringency scores correspond to the top 1% and 5% of sequence matches, respectively.
e Peptide phosphorylation (15).
f Phosphoproteomics (30–32).
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ments the concentration of ERK2 added to TPPP was reduced
which resulted in the incorporation of 1.3 mol P/mol protein.
This partially phosphorylated TPPP exhibited low tubulin
polymerization activity (Fig. 5D). TEM showed that, in sharp
contrast to the control, the sample mainly consists of thread-
like oligomers, which form a loosely arranged network instead
of densely packed knobs (Fig. 6C). We conclude that the phos-
phorylation strongly impedes the ability of TPPP to promote
the formation and bundling of intactMTs, as well as tomediate
the formation of large tubulin/TPPP aggregates.
DISCUSSION
Previous data, based on the co-purification of TPPP with
Cdk5 and on the in vitro phosphorylation of three selected pep-
tides by Cdk5, suggested that TPPP could be a phosphoprotein
(15). In this work we identified the specific sites targeted by
protein kinases involved in brain signaling processes. Ser/Thr-
Pro motifs were found to be phosphorylated by both ERK2
(Ser18 and Ser160) and Cdk5 (Thr14, Ser18, and Ser160). It should
be noted, that from the stoichiometry of phosphate incorpora-
tion (see Fig. 1) as well as from the bioinformatic prediction,
three phosphorylation sites can be inferred for ERK2 (see Table
3). Thus, it is likely that Thr14 is also phosphorylated by ERK2,
although the modification of this residue was not found byMS.
Cdk5 and ERK1/2 share common sites in the tau protein (29);
therefore, the cross-talk between these two kinases may occur
in the case of TPPP phosphorylation as well. In addition, we
found that TPPP was phosphorylated by PKA at Ser32, Thr92,
and Ser159. The fact that the truncated 3-43TPPP carrying
Ser160 as potential phosphorylation site was modified only to a
stoichiometry of 0.4–0.5 mol P/mole protein, suggests that the
major sites of these kinases are localized in the N-terminal
region. This idea was further supported by the in vivo phospho-
rylation data from our and other laboratories. We isolated
TPPP from bovine brain, and identified the phosphorylated
amino acid residues as Thr12, Ser16, and Ser30. Recent pro-
teomic analysis of in vivo phosphorylated human and mouse
synaptic proteins (30–32) identified the same sites although
there is a 1 or 2 amino acids shift between the sequences (Fig. 3).
These sites of TPPP obtained by prediction as well as identified
in vitro and in vivo (see Table 3) are the major targets of the
kinases in the brain.
The N-terminal tail of TPPP (1–52 amino acids) was pre-
dicted to be completely disordered (8). The amino acid
sequence of disordered proteins and protein regions is con-
sidered to be much less conservative than that of the struc-
tured ones (33, 34). Indeed, in the polypeptide sequences of
vertebrate TPPPs, we found 25% identity between mammals
and fishes in the N-terminal segment as compared with 75%
identity in the C-terminal part (data not shown). However,
the putative phosphorylation sites in the more variable
N-terminal region are maintained during evolution (Fig. 3)
indicating a physiological role for the phosphorylation of
these residues.
Interestingly, Ser159/Ser160 of bovine and human TPPP was
not found to be phosphorylated in vivo. As demonstrated in Fig.
3B, the neighboring sequence (163–187 amino acids) has high
homology with the tubulin binding domain of tau protein. It is
possible that in the intracellular milieu these sites are masked
by the association of tubulin/MT to TPPP.
All of these observations suggest the modulation of TPPP
activity by phosphorylation. It is likely that in this process ERK2
plays a dominant role because of its direct binding to TPPP. In
fact, by MotifScan we identified two regions of TPPP that
resemble the ERK docking site called D domain (28). Although
it is not known whether all ERK-interacting molecules have D
domains, the existence of such a region together with our affin-
ity binding experiment indicate that ERK2 is, indeed, a poten-
tial interacting partner and regulator of TPPP.
FIGURE 4. Identification of ERK2 as an interacting partner of TPPP in bovine brain extract. A, SDS/PAGE analysis of the proteins bound to the TPPP affinity
column. Lane a, TPPP-binding proteins eluted from the column; lane b, 1.5g of GAPDH, and lane c, 1.5g of tubulin controls. B, ERK2 (NCBI acc. NP_786987)
identified from CID ofm/z 651.0 (2) matching peptide sequence Ac-AAAAAAGAGPEM(ox)VR (2–15). The b and y ions represent N- and C-terminal fragment
ions (38), water loss is marked as #,64 stands for methane sulfenic acid (CH3SOH) loss.
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In the present report we provided evidence for the inher-
ent ability of TPPP to induce self-assembly of MAP-free
tubulin, and for its extensive bundling activity (Fig. 6, A and
B), which is a MAP-like function,
similar to that of tau orMAP2 pro-
teins in brain. The resistance of
TPPP-bundled MTs against anti-
microtubular agents was recently
reported in human cells (3) sug-
gesting the potential physiological
role of this protein in the stabiliza-
tion of the microtubular network.
Our quantitative data showed that
the dissociation constants and the
stoichiometries for the complexes of
tubulin andTPPPaswell as of tubulin
and phosphorylated TPPP (2–3 mol
P/mol protein) did not differ signifi-
cantly; however, the secondary struc-
tural changes inducedby the complex
formation were found to be distinct
(Fig. 5, B andC). Therefore, it is likely
that the phosphorylation resulted in
some structural changes in the recog-
nitiondomain(s)ofTPPP.Asaconse-
quence of the perturbation of the
binding interface byphosphorylation,
a dramatic alteration in the tubulin
polymerizationpromotingpotencyof
TPPP was detected (Fig. 5D). In fact,
we found that the phosphorylation of
TPPP by ERK2 (or by Cdk5) but not
by PKA, blocks (Fig. 5D) the MT
assembling activity ofTPPP.Aplausi-
ble explanation of this finding is that
the phosphorylatedTPPP is unable to
induce appropriate conformational
changes required for the assembly of
tubulin dimers into protofilaments
and tubes.OurTEManalysis revealed
that limited phosphorylation ofTPPP
by ERK2 (1.3 mol P/mol protein
incorporated) exerted on one hand,
significant inhibitory effect on the
MT assembling activity of TPPP; on
theotherhand, it inhibited the forma-
tion of large amorphous protein
aggregates (Fig. 6C). Because our
recent immunofluorescent data on
HeLa cell and immunohistochemis-
try results on human brain samples
from patients suffering in synucle-
inopathies provided evidence for
the co-enrichment of TPPP with
tubulin in aggresome, Lewy body
and other inclusions (3, 5, 8), one
can hypothesize that within these
structures the TPPP molecules
are dominantly in unphosphorylated form, and suggest pos-
sible pathological relevance of the post-translational modi-
fication of TPPP.
FIGURE 5. Effect of phosphorylation on the interaction of tubulin and TPPP (A, B, C) and on the TPPP-promoted
tubulin polymerization (D).A, CD spectra of TPPP (dash-dot-dot line), themixtures of tubulin and TPPP (solid line), of
tubulinandERK2-phosphorylatedTPPP (dashed line). Final concentrationswere5Mand1MforTPPPandtubulin,
respectively. The stoichiometry of phosphorylation was 2.9 mol P/mol protein. B, titration of 1 M tubulin with
non-phosphorylated (f, solid line) and phosphorylated (E, dashed line) TPPP. The difference ellipticities at 207 nm
calculated fromtheellipticitiesmeasuredwith themixtureof thetwoproteinsandwith the individualproteinswere
plottedasa functionof theconcentrationofTPPP.Thestoichiometryofphosphorylationwas2.9molP/molprotein.
C, plotsof thedataof Fig. 5Baccording toWuandHammes (39).Kd values and the stoichiometriesof the complexes
obtained from the slope and the intercept on the ordinate, respectively, are 2.7M and 1.3, and 2.5M and 1.0, for
the unphosphorylated and phosphorylated TPPP, respectively. D, tubulin polymerization induced by addition of
TPPP before and after phosphorylation. Final concentrations were 7 M tubulin and 3 M TPPP (solid line) or 3 M
TPPP phosphorylated by ERK2 to the stoichiometry 2.9mol of P/mol protein (dashed line) or 1.3mol P/mol protein
(dotted line).
FIGURE6. TEM imagesof theTPPP-induced tubulinassembliesbefore (A,B) andafterphosphorylation (C)withERK2
(1.3 mol of P/mol protein). A and B, bundles of MTs sectioned at different angles and thread-like oligomers aggre-
gated into dense knobs are shown. The MTs are frequently covered by tiny projections and periodically arranged
dense particles (B), which form cross-links betweenMTs (see inset in panel B). C, sample preparedwith phosphoryl-
atedTPPP contains loosely arrangedoligomeric threads.Bars, 200nm inA andC; 100nm inB and50nm in the inset
in B.
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Cdk5 may have the same effect as ERK2 since it phospho-
rylates identical sites in TPPP. Because of the distinct specific-
ity, PKAhas a different substrate recognition preference: it pre-
dominantly phosphorylates Ser32 in the KRLS motif. The
phosphorylation of TPPP at this site occurs in vivo and may
have some important function but according to our in vitro
results it has no significant effect on the tubulin/MT system.
Therefore, we suggest that the functional consequences of
phosphorylation of Thr14 and/or Ser18 residues but not Ser32 in
the N-terminal region of TPPP play a crucial role in the regula-
tion of the MT assembly and stabilization of the microtubular
network. Because the phosphorylation pattern of a proteinwith
multiple phosphorylation sites depends on the coordinated
action of protein kinases and phosphatases (35) further inves-
tigations are needed to clarify the detailed regulatory mecha-
nisms modulating the functions of TPPP. The significance of
the phosphatases in the regulation has been underlined by the
example of tau protein that is dephosphorylated by several pro-
tein phosphatases (36, 37).
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